bidmc-cancercenter.bsky.social
We better the lives of patients with cancer, leveraging transformative science and pioneering therapies to provide highly personalized and compassionate care accessible to all.
👤 Joined on 18 November 2024
Followers
Following
Total Posts
@bidmc-cancercenter.bsky.social💡Our real-world analysis showed median time to consolidative #immunotherapy of 84 days from CRT start in Stage III #NSCLC (2018-2021). Uninsured, Medicaid, and tx at non-academic center associated w/ longer time to intiation #ASCOQLTY26 @bidmc-cancercenter.bsky.social @ascocancer.bsky.social
Show PostOur paper is finally out! We discovered that FAH is enriched in HR+ breast cancer where it drives treatment resistance via a novel non-canonical function
Show PostThe Plenary Session at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 has ended. Experts are now answering questions on Mednet. Head to the Q&A → gqr.sh/QpfP #ASTRO26 #RadOnc #ClinicalTrials #CancerResearch #MedEd
Show PostPRESS RELEASE: NRG Oncology Trial Results Show No Survival Benefit with the Use of Proton Therapy for Patients with Advanced Hepatocellular Carcinoma #ASTRO26 - Read the Release: https://ow.ly/Nm8C50ZPKWZ
Show PostNOW AVAILABLE! Join us as we break down the results of NRG-CC009 and NRG-GI003 presented in the #ASTRO26 Plenary Session. Find the NRG Oncology Podcast on Spotify, Apple Podcasts, Amazon, YouTube and stream www.NRGOncology.org/Podcast
Show Post